No Data
No Data
US Drugmaker Viatris Q2 Earnings Edge Out Analysts Expectation On Strong Demand For Branded And Generic Drugs
Earnings Call Summary | Viatris(VTRS.US) Q2 2024 Earnings Conference
Nasdaq, S&P, Dow Climb as Drop in Jobless Claims Moves Stocks Back Into Rebound Mode
Viatris Hits Seven-month High After Q2 Beat
Earnings Summary: Viatris Tops Q2 Results, Revises FY2024 Outlook to Reflect Divestiture Impact
Express News | Viatris Shares up 2.9% Premarket After Q2 Results Beat
No Data
Ape Power : KEN GRIFFIN COMMITTED FRAUD LIVE ON AIR! - AMC Stock Short Squeeze Update